La dernière actualité médicale HaemophiliaXPERT Consultez la version en ligne Chère consœur, cher confrère, Retrouvez ci-après les dernières publications scientifiques issues de revues à comité de lecture dans votre domaine d'expertise. Publications du Jeudi 13 mars 2025 Assessment of joint health in females with haemophilia: The carriers ultrasound project (CUP) study Haemophilia 2024; 30(6): 1422-8 Haemophilia is an X‐linked recessive bleeding disorder associated with deficient production of coagulation factors VIII (FVIII) or IX (FIX). Males with severe haemophilia (<1% factor level) are... En savoir plus |  Version PDF  |  Imprimer l'abstract Recombinant factor VIIa: new insights into the mechanism of action through product innovation Research and Practice in Thrombosis and Haemostasis 2025; 9(1): 102670 Management of bleeding in persons with hemophilia and inhibitors involves treatment with bypassing agents, including recombinant activated factor VII (rFVIIa). Two rFVIIa products are commercially approved... En savoir plus |  Version PDF  |  Imprimer l'abstract Changes in Hemophilia Treatment in the Eastern Part of Germany between 2015 and 2021-Data from the Kompetenznetz Hmorrhagische Diathese Ost (KHDO). Hamostaseologie 2025 Feb  Treatment options for patients with hemophilia (PWH) have changed substantially in the last years. This study aimed to compare hemophilia treatment in the eastern part of Germany in 2021 with data... En savoir plus  |  Free Full-text Emerging Therapies in Hemophilia: Improving Equitable Access to Care. Journal of blood medicine 2025 ; 16: 95-115 In recent years, gene therapy and bio-engineered hemostatic molecules have revolutionized treatment for people with hemophilia. These innovative therapies aim to decrease treatment burden and improve patient... En savoir plus  |  Free Full-text Accueil  |  Actualités  |  Archives Informer un confrère | Modifier votre profil | Supprimer mes données | Sources et critères Copyright 2025 © GNM Healthcare Group Companies USA, Inc.